CT News and Research

RSS

ePlus Technology renews IT products and services agreement with VHA

ePlus inc. today announced that its wholly owned subsidiary, ePlus Technology, Inc., has renewed its agreement with VHA Inc., a nationwide network of not-for-profit hospitals that work together to improve clinical and economic performance. ePlus will offer IT products and services as well as leasing services for IT and medical equipment to more than 1,400 VHA member healthcare institutions and 28,000+ non-acute facilities nationwide.

16 Aug 2010

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

In a move likely to secure its place as a leading provider of medical radiation countermeasures, Humanetics Corporation today announced that it has secured exclusive worldwide licenses to two new treatments that provide short and long-term post-exposure protection from ionizing radiation acquired during a terrorist act, nuclear or radiological attack or accident, as part of cancer radiotherapy or even during routine diagnostic CT scans.

13 Aug 2010

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

The Boston Globe: "With a few computer keystrokes, Massachusetts physicians will soon be able to identify patients who travel from clinic to clinic in pursuit of potent prescription drugs that feed lethal addictions. State health regulators yesterday unanimously approved the new detection system designed to stop 'doctor shopping' by addicted patients who try to dupe doctors into prescribing narcotics. The practice, specialists said, has fueled a surge in drug-related deaths in Massachusetts" (Smith, 8/12).

13 Aug 2010

AVEO achieves enrollment target for tivozanib global Phase 3 clinical trial in advanced renal cell carcinoma

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.

12 Aug 2010

Clinical cases that use IQQA-Liver for operative assessments exceed 1000: EDDA Technology

EDDA Technology announced today that the number of clinical cases evaluated for pre- and post- operative assessment using IQQA-Liver in hospitals has exceeded 1000 examinations, since the first commercial system installation in Q2 2009. EDDA's IQQA-Liver, now marketed worldwide, is a comprehensive workflow solution supporting modern multidisciplinary liver imaging evaluation and management.

12 Aug 2010

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.

12 Aug 2010

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has completed the previously announced acquisition of the New Jersey operating subsidiary of Health Diagnostics.

12 Aug 2010

Today's Opinions and Editorials: The importance of following health reform's plan and more about 'death panels'

Within a few years, 6 million uninsured California residents will finally get medical coverage as part of the newly passed federal health care reforms. But what will they pay? And who will regulate premiums as insurers angle for customers? (8/11).

12 Aug 2010

NMDP applauds introduction of 'Stem Cell Therapeutic and Research Reauthorization Act of 2010'

The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.

11 Aug 2010

FDA clears RyMed's InVision-Plus CS needleless IV connector

RyMed Technologies announced today that it has received FDA 510(k) clearance for its newest IV connector, InVision-Plus® CS™ with Chlorhexidine-Silver Ion Engineering.

10 Aug 2010

Today's OpEds: U.S. vs. Nordic health care; Medicare solvency; Patients and health costs; Mystery of ACOs

Beginning, like the United States, with excellent intentions, [each of the Nordic countries'] health care system evolved similarly. Initially, all care was covered. But costs rose. The government covered fewer illnesses. Expensive treatments increased government spending. ... This is not an evolution that the U.S. can avoid (Mark B. Constantian, 8/8).

9 Aug 2010

RadNet second-quarter revenue increases 6.0% to $139.0 million

9 Aug 2010

Aquilion ONE 320-detector row CT system reduces radiation exposure

When pediatric patients are imaged using CT, reducing sedation and radiation dose while maintaining the best possible image quality is paramount in delivering care. To provide patients with high-quality CT exams and a reduction in sedation and radiation dose, leading children's hospitals are installing Toshiba America Medical Systems, Inc.'s Aquilion ONE 320-detector row CT system.

9 Aug 2010

FDA proposed rules address industry, consumer concerns

The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.

6 Aug 2010

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

6 Aug 2010

SeraCare optimizes ACCURUN 341 Nucleic Acid Positive controls

SeraCare Life Sciences, Inc. today announced that the Company has developed a new series of controls in its ACCURUN portfolio to monitor and validate molecular diagnostic test performance for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG). Through collaboration with instrument and reagent manufacturers, SeraCare has optimized the ACCURUN 341 Nucleic Acid Positive controls specifically for use with the three most popular assays currently on the market; the Gen-Probe APTIMA Combo 2 Assay, the Roche COBAS AMPLICOR CT/NG Test, and the Becton, Dickinson BD ProbeTec ET System.

6 Aug 2010

Foam in helmets, armor can cause injury

In a counter-intuitive finding, scientists at New York University (NYU) and Polytechnic Institute of New York University (NYU-Poly) report that the foam used in helmets and other body armor indeed absorbs damage when compressed slowly but can cause as much injury as a hard object when hit at high speeds.

5 Aug 2010

ECRI Institute and Silverchair relaunch AHRQ's updated NGC, NQMC Web sites

ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, and its technology subcontractor, Silverchair, today announce the relaunch of two key healthcare Web sites they have developed for the U.S. Agency for Healthcare Research and Quality (AHRQ). The National Guideline Clearinghouse™ (NGC™), www.guideline.gov, and the National Quality Measures Clearinghouse™ (NQMC™), www.qualitymeasures.ahrq.gov, now feature updated design elements, enhanced search functionality, and easier access to all content.

5 Aug 2010

FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy

The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.

5 Aug 2010

Fractures are major concern for U.S. high school athletes: Study

The popularity of high school sports in the United States has continued to increase over the past decade, with more than 7.5 million athletes participating in school sports during the 2008-09 academic year. A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that 95 percent of fractures required costly diagnostic imaging, including X-rays, MRIs and CT scans, and 16 percent required surgical repair.

4 Aug 2010

CT News and Research

ePlus Technology renews IT products and services agreement with VHA

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

AVEO achieves enrollment target for tivozanib global Phase 3 clinical trial in advanced renal cell carcinoma

Clinical cases that use IQQA-Liver for operative assessments exceed 1000: EDDA Technology

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

Today's Opinions and Editorials: The importance of following health reform's plan and more about 'death panels'

NMDP applauds introduction of 'Stem Cell Therapeutic and Research Reauthorization Act of 2010'

FDA clears RyMed's InVision-Plus CS needleless IV connector

Today's OpEds: U.S. vs. Nordic health care; Medicare solvency; Patients and health costs; Mystery of ACOs

RadNet second-quarter revenue increases 6.0% to $139.0 million

Aquilion ONE 320-detector row CT system reduces radiation exposure

FDA proposed rules address industry, consumer concerns

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

SeraCare optimizes ACCURUN 341 Nucleic Acid Positive controls

Foam in helmets, armor can cause injury

ECRI Institute and Silverchair relaunch AHRQ's updated NGC, NQMC Web sites

FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy

Fractures are major concern for U.S. high school athletes: Study

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News